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Background: Increasing number of cases with small supernumerary marker chromosomes (sSMCs) without
centromeric DNA and dozens of cases with trisomy 2q3 have been reported in recent years. However, cases of
simultaneous sSMC and partial trisomy of chromosome 2q have been rarely described.
Results: We report the case of a young girl patient with growth retardation and mild facial features due to a partial
trisomy 2q33.3-37.3. The 34.3 Mb-duplication of the 2q33.3 to q37.3 region found in the patient constituted a
supernumerary inverted duplicated neocentric marker chromosome.
Conclusions: This is the first case of a patient with partial trisomy 2q33.3-37.3 presenting an inverted duplicated
neocentric marker chromosome. Based on the case, this study will help further understanding the genotype/
phenotype correlations of partial 2q3 duplication and exploring the relationship between neocentric sSMC and
human diseases.
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Small supernumerary marker chromosomes (sSMCs),
which are detected in approximately 0.075% of prenatal
specimens and 0.044% of newborn infants [1], are defined
as structurally abnormal chromosomes that cannot be
unambiguously identified or characterized by conventional
banding cytogenetics alone [2]. In general, they are equal
or smaller in size than chromosome 20 of the same meta-
phase spread. According to the literature, sSMCs are most
often found in mentally retarded patients (0.288%), and
followed by infertile patients (0.125%) [1]. sSMCs consti-
tute a morphologically heterogeneous group appearing as
different types of inverted duplicated-, ring-, or minute
chromosomes. During meiosis and mitosis, the centro-
mere controls the segregation of the genetic material. In
the absence of endogenous centromeres, the rearranged
chromosomes would either be lost or become acentric.* Correspondence: wulingqian@sklmg.edu.cn
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unless otherwise stated.While most human marker chromosomes appear to
contain normal human centromeres with detectable alpha
satellite DNA [3], stable sSMC that do not contain any
known centromeric DNA have been increasingly reported
in recent years. These sSMC contain a region called “neo-
centromere” acting as a functional centromere that has
not been known to have a centromere function previously.
In this report, we present a case of partial trisomy 2q
in a girl with neocentric sSMC. To the best of our know-
ledge, pure partial trisomy of chromosome 2q3 with the
absence of associated monosomy is rare. This is the first
report on the molecular cytogenetic characterization of




The patient, a 2-year-old girl, was referred to our center
because of growth retardation, distinctive facial features,
and chromosomal abnormalities identified at another
hospital. She was delivered at term via cesarean section as
the first child to non-consanguineous Chinese parents.s is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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birth was 2.2 kg (~0.4th percentile), and no significant
hypoxia, jaundice, or other complications were recorded
at birth. The parents were 26 (mother) and 31 (father)
years of age at the time of the birth. They were both
healthy with normal karyotypes. Approximately 40 days
into pregnancy, the mother had taken traditional Chinese
medicine because of high temperature. After the baby was
born, she had jaundice and was treated for six days.
Although she could sit alone without assistance at nine
months of age, she is still unable to walk alone at age 2,
suggesting a delay in psychomotor milestones. Speech
retardation also existed because she cannot have a dialogue
with others except for some simple words such as “Mom”
and “Grandma.” Physical examination showed a height
of 86 cm (~50th percentile) and weight of 11 kg (~25th
percentile). She had mild facial dysmorphic features,
including ocular hypertelorism, epicanthus, upslanted
palpebral fissures, flat nasal bridge, and protruding ear.
No other obvious abnormalities were observed to date.
Results
Analysis of GTG-banded chromosomes in the propo-
sita revealed a supernumerary marker in all analyzedFigure 1 Cytogenetic and molecular results. (a) G-banding partial karyot
with a marker chromosome. (b) C-banding showing no centromeric hete
loci along chromosome 2 using Illumina Human OmniZhongHua-8 Beadc
(nt. 208775856–243044147) in terminal end of 2q (Red arrow ). (d) FISH results
and RP11-119B15 (green) at 2p22.3 as a control probe, showing an orange sign
2, while the other one lacking the orange signal. Two orange hybridization sign
marker. (e, f) FISH results of the parents showing one hybridization signal for eametaphases; however, a 2q deletion was observed
(Figure 1a). C-banding (Figure 1b) showed the absence of
centromeric heterochromatin in the marker chromosome,
suggesting the presence of a neocentric sSMC. The parents’
karyotypes were normal, indicating a de novo marker
chromosome. SNP array analysis detected a 34.3 Mb-
duplication (nt.208775856-243044147) of the 2q33.3 to
q37.3 region (Figure 1c). The proximal breakpoint was
mapped within a 7.5 kb region between SNPs rs2621470
and rs2621472 (nt.208768367-208775856) at 2q33.3,
while the distal breakpoint was located in the last SNP
rs12469535 at 2qter (position 243044147). Considering the
result of banding cytogenetics and copy number variation
analysis, we supposed that this supernumerary marker
chromosome arose from chromosome 2. We confirmed
the chromosome 2 origin with FISH analysis using a
BAC clone RP11-526 L8 (orange) within the duplicated
region in the patient and her parents (Figure 1d, e, and f).
FISH studies also showed that the marker chromosome
has some features of an isochromosome. The combined
results proved that the supernumerary marker chromo-
some was derived de novo from chromosome 2 and
corresponded to an inverted duplication conformation.
Finally, we described the karyotype of the proposita asypes of the patient, indicating a terminal deletion of 2q, accompanying
rochromatin. (c) Copy number variation analysis for individual SNP
hip. B Allele Frequency and Log R show a gain of 34,268,291 bp
of the patient. FISH using RP11-526 L8 (orange) at 2q37.3 as a test probe
al and a green signal on each of the two copies of only one chromosome
als for test probe on the SMC corresponding to an inverted duplication
ch probe on the two normal chromosomes 2.
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neo→ q33.3→ qter).
Discussion
Till date, dozens of cases with trisomy 2q3 have been
reported in the literature, most of which are associated
with monosomy of another chromosome segment [4].
Majority are the result of an abnormal segregation of the
parents chromosome rearrangement. In contrast, pure
duplication of 2q3 is relatively rare. In the present study,
we report a case of pure partial trisomy 2q33.3-q37.3. The
proband, a 2-year-old girl displays mild facial dysmorphic
features and has a delayed development similar to the
known clinical features of the 2q3 duplication syndrome
[5-7]. To our best knowledge, only 14 cases with isolated
duplications of 2q overlapping 2q33-2qter have been
previously described [4,8-19]. Majority of these cases
(Table 1) are de novo and an inverted duplication is the
most common form of rearrangement. Patients reported
with duplication of 2q33-2qter also have similar clinical
phenotypes, including variable developmental delays, facial
and visceral anomalies, and trunk and limb malformations.
Mild to moderate growth and mental retardation were
documented in all cases except in the one without growth
retardation [11]. Characteristic facial features were noticed
in the neonatal period, including hypertelorism and epi-
canthic folds, broad flat nasal bridge, anteverted nostrils,
long philtrum, thin upper lip, low-set ears, Cupid’s bow
lip, and micrognathia. Minor visceral anomalies reported
in some patients mainly involve cardiac, kidney or brain






Dennis et al., [8] 2q33-2q37 Ins 12q23 Pat
Yu and Chen, [9] 2q34-2q37 Inv dup De
Kyllerman et al., [10] (2 cases) 2q34-2qter Inv dup Pat
Dahoun-Hadorn and
Bretton-Chappuis, [11]
2q35-2qter Inv dup De
Romain et al., [12] 2q33.1-2q35 Dir dup De
Fritz et al., [13] 2q35-2q37.1 Ins 17q25 De
Seidahmed et al., [14] 2q32-2q37 Inv dup De
Angle et al., [15] 2q34-2qter Inv dup Mat
Bonaglia et al., [16] 2q33-2q37 Inv dup De
Bird and Mascarello, [17] 2q33.1-2q37.1 Dir dup De
Slavotinek et al., [18] 2q33-2q37.3 Inv dup De
Hermsen et al., [4] 2q35-q37.3 Trans dir dup De
Pietrzak et al., [19] 2q35-q36 Sup r De
Ins, insertion; Inv dup, inverted duplication; Dir dup, direct duplication; Trans dir du
Pat., paternal.
*The mentally retarded child presented with comparable facial anomalies, hypospacommon acral anomalies include fifth-finger clinodactyly,
brachydactyly, and abnormal palmar or flexion creases.
Overall, the clinical phenotypes of our proposita in this
study are gentle and equivalent to those in the literature,
yet visceral and limb malformations were not observed.
Compared with other chromosome disease syndromes,
most phenotypes of the 2q3 duplication syndrome are
shared with other syndromes.
In this report, we describe the special rearrangement
form in our patient, a de novo inverted duplication
marker chromosome verified by cytogenetic and mo-
lecular analysis. Because the karyotype 47, XX, del(2)
(pter→ q33.3), +mar were detected in 100% cells and no
heterochromatic region was found, we speculated that the
marker carried “a newly derived centromere” to support
its stability. The first human neocentromere lacking alpha
satellite DNA was discovered by Voullaire in 1993 [20].
Since then, increasing numbers of new cases with neocen-
tromere have been reported in the literature. Based on his
analysis of 93 cases of neocentromere formation, Marshall
et al. suggested “hotspots” of neocentromere formation.
They found that certain regions of some chromosomes
seemed particularly prone to form neocentromeres, such
as 3q, 8p, 13q, and 15q, although the specific mechanism
remains unclear [21]. Earlier studies have reported several
similar cases with neocentromere markers that are origi-
nated from other chromosomes (Table 2). A review of
these cases revealed that the major type of rearrangement
of these mirror-image markers was terminal deletion
accompanying with inverted duplication, which was also






. + +/+ +
novo + +/− +
. + +/+ +
novo +* +/+ +
novo + +/− +
novo + +/+ +
novo + +/+ +
. + +/+ +
novo + +/+ +
novo + +/+ +
novo + +/− +
novo + +/− +
novo + +/− +
p, translocation direct duplication; Sup r, supernumerary ring; Mat., maternal;
dias and bilateral cryptorchidism, but without growth retardation.
Table 2 Comparison of similar cases with inverted duplicated neocentric sSMC
Case number Karyotype and grade
of mosaicism




1 47,XX,del(1)(q32),+der(1)(qter→ q32::q32→ qter)[100%] Terminal deletion + Inv dup(possibly) NOR 01-N-q32/1-1
2 47,XX,del(9)(p12),+der(9)(pter→ p12::p12→ pter)[100%] Terminal deletion + Inv dup NOR 09-N-pt12/1-1
3 47,XY,del(11)(q22),+der(11)(qter→ q22::q22→ qter)[100%] Terminal deletion + Inv dup NOR 11-N-qt22/1-1
4 47,XX,del(13)(q32.3),+der(13)(qter→ q32.3::q32.3→ qter)
[100%]
Terminal deletion + Inv dup NA 13-N-qt32.3/2-1
5 47,XX,del(14)(q32.1),+der(14)(qter→ q32.1::q32.1→ qter)
[100%]
Terminal deletion + Inv dup NOR 14-N-qt32.1/1-1
6 47,XY,i(16)(q10), +der(16)(p13.3p11.2)[100%] Deletion + Iso NOR 16-N-p11.2/1-1
7 47,XY,del(17)(q22q23),+der(17)(:q22→ q23::q23→ q22:)
[100%]
Interstitial deletion + Inv dup NOR 17-N-qt22/1-1
8 47,XX,del(20)(p11.2),+der(20)(pter→ p11.2::p11.2→ pter)
[100%]
Terminal deletion + Inv dup NOR 20-N-pt11.2/1-1
9 47,XX,del(2)(q33.3),+der(2)(qter→ q33.3::q33.3→ qter)[100%] Terminal deletion + Inv dup NOR the present case
Inv dup, inverted duplication; Iso, isochromosomes; NA, not available for testing; NOR, normal.
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for the long arm of chromosome 16 and an acentric
neocentric marker derived from the short arm of chromo-
some 16. Yet essentially, the likely mechanism of this
complex rearrangement is also a deletion accompanying
with inverted duplication. All the markers of these cases
formed almost de novo. Mental retardation or delayed
psychomotor development combined with physical handi-
caps could be observed in all probands of these cases, and
the other clinical features of each proband were corre-
sponding to the characteristics of each trisomy syndrome
fundamentally. In our study, the neocentric sSMC is an
inverted duplication chromosome derived from the distal
region of chromosome 2q. To date, there are only two
constitutional neocentromere cases with sSMC involving
chromosome 2 described in the literature: one involving a
ring marker chromosome from an interstitial deletion
(paracentric) and the other a supernumerary ring. To the
best of our knowledge, in partial trisomy 2q syndrome,
this form of an inverted duplication neocentric chromo-
somal rearrangement with a deleted chromosome com-
plementary for the region of duplication has not been
previously reported.
Considering the mechanism of neocentric sSMC for-
mation, many different theories have been proposed. At
present, ring and inv dup shaped neocentric sSMC are
mainly reported. Ring neocentric chromosomes are mainly
due to McClintock mechanism [22], which is in connec-
tion with a balanced situation in the carriers. For forma-
tion of inv dup shaped sSMC, as summarized by Liehr
et al. [23], Marshall et al. [21] and Murmann et al. [24],
these markers may form either in meiosis or mitosis. The
majority are based on a U-type exchange between two
homologous chromosomes at meiosis I, resulting in tetras-
omy for the terminal chromosomal region present on the
marker, while the remaining inv dup markers may comefrom other mechanisms leading to partial trisomy of that
region in the genome. Our patient carries an apparent
terminal deletion at chromosome 2q accompanied with a
neocentric inverted duplication chromosome. Because no
chimerism was found in our patient and in other patient
reports with analogous rearrangements, we believed that
the break could not occur during a mitotic event, other-
wise mosaicism would be observed. In view of the above
facts, we speculate that the most plausible explanation is a
distal U-type exchange occurring between two chromatids
of the same chromosome at meiosis II (Figure 2). A
double-chromatid break occurred when the sister chroma-
tids were about to separate during the second meiosis.
Subsequently, two broken chromatids would be dragged
into two hemizygotes in effect of traction, while the
acentric chromosomal fragment resulting from crossover
mistakes of the chromatids might segregate with one of
them. Neocentromerization occurred at any location once
the inv dup marker chromosome had been formed. After
fertilization and subsequent replication in early zygote
development, the endpoint would be partial trisomy in the
form of the stable marker. This is the situation seen in our
patient. To validate our speculation, we used simple quan-
titative fluorescent polymerase chain reaction (QF-PCR)
to perform short tandem repeat analysis (Figure 3).
Copy number variation occurring after the homologous
chromosomes separation in meiosis can generate allele
homologous repeats. Moreover, in trisomic diallelic cases,
two out of three chromosomes share the same loci so that
a pattern of 2:1 ratio between two peaks will be detected
which coincides with our result. According to the evalu-
ation criteria of QF-PCR [25], we can consider that
the extra chromosome segment in our patient results
from homologous paternal allele duplication. However,
due to the lack of a satellite centromeric specific probe,
the specific location of the neocentromere cannot be
Figure 2 Possible mechanisms for the formation of neocentric marker chromosome in the patient. Chromatids breakage (red scissors) and a distal
U-type exchange happened before sister chromatid separation during the meiosis II. Neocentromerization occurred once breakage happened. Deep color
ovals are the centromeres, and the same one on the acentric fragment is neocentromere. The broken ends (red wave) of the centric fragment could be
stabilized by telomere restitution. After zygogenesis and subsequent replication the result would be partial trisomy for the duplicated fragment.
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unknown.
Among the reported cases, majority of neocentric
marker chromosomes were derived from chromosomal
arms or telomeric regions [21,26,27] containing a higher
density of euchromatic sequences than centric sSMC.
This may explain the strong correlation (~90 percentile)
between neocentric sSMC and abnormal phenotype [28].
According to the literature, the critical region correlating
with clinical features, including facial dysmorphism, post-
natal growth retardation, syndactyly, and visceral hypopla-
sia, has been preliminarily mapped within the 2q34-qter
interval [29]. We reviewed 56 virulence genes contained
in the 2q33-2qter duplication region observed in our pa-
tient and found that four genes may determine the pheno-
type: TM4SF20 (OMIM:615404), PDE6D(OMIM:602676),
HDAC4(OMIM:605314), and KIF1A(OMIM:601255).
Among patients with developmental delay, speech
impairment, and/or brain imaging abnormalities, a hetero-
zygous 4 kb-deletion of the TM4SF20 was identified byFigure 3 Microsatellite analysis of markers D2S1279 and D2S1338 on
peaks areas in the proband indicated that she inherited a double dosage oWiszniewski et al. [30]. Thomas et al. reported a PDE6D
mutation in two siblings with Joubert syndrome displaying
intrauterine growth retardation, facial dysmorphism,
postaxial polydactyly of the feet, syndactyly, and other
symptoms [31]. Patients with brachydactyly mental retard-
ation syndrome resulting from a mutation, deletion, or
interruption in HDAC4 have been described with an
analogous phenotype in a report [32]. Mutations in KIF1A
caused nonsyndromic intellectual disability in a patient
described by Hamdan et al. [33]. The phenotype associ-
ated with these four disease-causing genes are overlapping
with the one observed in our patient, although no syndac-
tyly and visceral anomalies were seen in our patient. This
discrepancy may be due to the fact that the pathogenicity
of genes is mainly determined by interrupted or deleted
variants rather than duplications. Genes are dosage-
sensitive and become defective by loss rather than by gain
of function. Furthermore, we also noticed that the
chromosome 2q35 duplication syndrome (OMIM:185900)
was located within the duplication interval in ourABI 3100 genetic analyser. The 2:1 ratio between two fluorescent
f one of the paternal alleles.
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type I and Philadelphia-type craniosynostosis. Klopocki
et al. [34] identified a 59 kb microduplication at the
IHH (OMIM:600726) locus on chromosome 2q35 and a
minimum region of 9.1 kb region located 40 kb 5’ of
the IHH gene, in three families associated with variable
degrees of syndactyly and craniosynostosis. Our patient
carries this microduplication but does not have these
characteristics, showing only mild facial dysmorphism
and delayed psychomotor development. One reason
may be because of the broader duplicated region which
encompasses more genes and gene regulatory regions.
A large fragment repeat of the gene regulatory region
may act as a group affecting gene expression differently,
by controlling the expression of genes either within the
region or outside, therefore, resulting in different phe-
notypes. Moreover, this novel rearrangement may lead
to chromatin changes, and the presence of the neocen-
tromere in the marker chromosome may influence gene
expression [35]. Finally, it is difficult to explain a clear
genotype/phenotype correlation for the 2q3 duplication
syndrome because of variable clinical situations and the
ambiguous breakpoints. The specific pathogenesis remains
to be explored with precise breakpoint position mapping
and related functional studies.
Conclusions
In conclusion, we report the first case of a patient with
partial trisomy 2q33.3-37.3 presenting an inverted dupli-
cated neocentric marker chromosome. Our patient had
only facial dysmorphism and developmental delay as
opposed to the previously described phenotype found with
pure partial trisomy of chromosome 2q3. We defined the
origin of the duplication fragment and analyzed the
rearrangement and the patient’s phenotype which will help
further understanding of the genotype/phenotype correla-
tions of partial 2q3 duplication and exploring the relation-
ship between neocentric sSMC and human diseases.
Methods
Cytogenetic analyses were performed on metaphase
chromosomes of the patient and her parents derived
from peripheral blood lymphocytes cultures. G-banding
(400–550 bands) was performed first, according to the
standard procedure. However, to further determine whether
sSMCs found in GTG-banding karyotype contained centro-
meres, we performed C-banding which highlighted hetero-
chromatic regions.
Genomic DNA of the patient was extracted from fresh
peripheral blood using the standard phenol/chloroform
method. SNP array analysis of the extracted DNA was
performed using the Human OmniZhongHua-8 Beadchip
(Illumina, San Diego, CA) with an average resolution of
3.34 Kb. The arrays were scanned on a microarray scannerand analyzed using GenomeStudio (cnv Partition Plug-in
v3.1.6) software. The operative procedures mentioned
above were all performed according to the manufacturer’s
recommended protocols (www.illumina.com).
In order to verify the possible pathogenic copy number
variations and determine their origin, FISH analysis was
performed on metaphase or interphase chromosomes from
the patient and her parents. We used two BAC clone
probes, RP11-526 L8 (orange) at 2q37.3 as a test probe, and
RP11-119B15 (green) at 2p22.3 as a control probe.
Consent
Written informed consent was obtained from the parents
of the patient for publication of this Case report. A copy
of the written consent is available for review by the
Editor-in-Chief of this journal.
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